Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07336134 · ClinicalTrials.gov registry record · NA
PopSci CHW4CervixHealth
A NA study of Cervical Cancer and Human Papilloma Virus, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07336134 is a NA study of Cervical Cancer and Human Papilloma Virus that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 120 participants, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07336134, a NA study of Cervical Cancer and Human Papilloma Virus, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Phase I: Validating self-collection kit by comparing their results with clinical Pap smear results in a cohort of 20 patients. Phase II: Evaluate the feasibility and acceptability of the CHW4CervicalHealth: Use of a self-collection kit to improve cervical health screening intervention aimed to promote HPV self-collection uptake among screening-eligible and under-screened ethnic minority women in the community.
Conditions Studied
Interventions
- DEVICE Evalyn® Brush
- DEVICE Copan Floqswab
- BEHAVIORAL CHW4CervicalHealth
Study Locations (1)
Pennsylvania
- Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-10-22 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07336134
The ClinicalTrials.gov registry entry for NCT07336134 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (79% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cervical Cancer appearing as the primary indexed condition, and to 3 interventions - of which Evalyn® Brush is the first listed.
NCT07336134 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07336134 about?
NCT07336134 is a clinical study titled "PopSci CHW4CervixHealth". Phase I: Validating self-collection kit by comparing their results with clinical Pap smear results in a cohort of 20 patients. Phase II: Evaluate the feasibility and acceptability of the CHW4CervicalHealth: Use of a self-collection kit to improve cervical health screening intervention aimed to prom...
What is the current status of trial NCT07336134?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-10-22. Estimated completion is 2026-07-01.
What conditions does trial NCT07336134 study?
This clinical trial studies the following conditions: Cervical Cancer, Human Papilloma Virus, Hpv, HPV Infection.
What interventions are being tested in trial NCT07336134?
The interventions under investigation include: Evalyn® Brush (DEVICE), Copan Floqswab (DEVICE), CHW4CervicalHealth (BEHAVIORAL).
Who is sponsoring clinical trial NCT07336134?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07336134 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.